Citius Pharmaceuticals, Inc.

CTXR · NASDAQ
Analyze with AI
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Assets
Cash & Equivalents$3,252$26,481$41,712$70,073
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$8,269$0$0$0
Other Curr. Assets$2,700$7,890$2,853$2,741
Total Curr. Assets$14,221$34,370$44,564$72,814
Property Plant & Equip (Net)$246$456$650$830
Goodwill$9,347$9,347$9,347$9,347
Intangibles$92,800$59,400$59,400$59,400
Long-Term Investments$0$44,915$0$29,177
Tax Assets$0$0-$39,931-$29,177
Other NC Assets$38-$44,877$39,969$38
Total NC Assets$102,431$69,241$69,435$69,615
Other Assets$0$0$0$0
Total Assets$116,652$103,611$113,999$142,429
Liabilities
Payables$4,927$2,927$1,165$1,277
Short-Term Debt$242$437$394$354
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$30,646$2,415$2,971$2,351
Total Curr. Liab.$35,815$5,779$4,530$3,982
LT Debt$21$263$481$678
Deferred Rev, NC$0-$6-$6-$5
Deferred Tax Liab, NC$6,714$6,138$5,562$4,986
Other NC Liab.$0$0$0$0
Total NC Liab.$6,735$6,401$6,043$5,664
Other Liabilities$0$0$0$0
Cap. Leases$263$481$678$855
Total Liabilities$42,550$12,180$10,573$9,646
Equity
Pref Stock$0$0$0$0
Common Stock$7$159$146$146
Retained Earnings-$201,370-$162,231-$129,688-$96,048
AOCI$0$0$0$0
Other Equity$271,440$252,904$232,368$228,084
Total Equity$70,077$90,831$102,826$132,182
Supplemental Information
Minority Interest$4,024$600$600$600
Total Liab. & Tot. Equity$116,652$103,611$113,999$142,429
Net Debt-$2,989-$25,781-$40,836-$69,040
Citius Pharmaceuticals, Inc. (CTXR) Financial Statements & Key Stats | AlphaPilot